These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25328373)

  • 1. TREATMENT TRIAL AND LONG-TERM FOLLOW-UP EVALUATION AMONG COMORBID YOUTH WITH MAJOR DEPRESSION AND A CANNABIS USE DISORDER.
    Cornelius JR; Salloum IM; Ferrell R; Douaihy AB; Hayes J; Kirisci L; Horner M; Daley DC
    Int J Med Biol Front; 2012; 18(6):399-411. PubMed ID: 25328373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults.
    Cornelius JR; Bukstein OG; Douaihy AB; Clark DB; Chung TA; Daley DC; Wood DS; Brown SJ
    Drug Alcohol Depend; 2010 Nov; 112(1-2):39-45. PubMed ID: 20576364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of cognitive behavioral therapy/motivational enhancement therapy (CBT/MET) in a treatment trial of comorbid MDD/AUD adolescents.
    Cornelius JR; Douaihy A; Bukstein OG; Daley DC; Wood SD; Kelly TM; Salloum IM
    Addict Behav; 2011 Aug; 36(8):843-8. PubMed ID: 21530092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder.
    Cornelius JR; Bukstein OG; Wood DS; Kirisci L; Douaihy A; Clark DB
    Addict Behav; 2009 Oct; 34(10):905-9. PubMed ID: 19321268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LONGER-TERM EFFECTIVENESS OF CBT IN TREATMENT OF COMORBID AUD/MDD ADOLESCENTS.
    Cornelius JR; Douaihy AB; Kirisci L; Daley DC
    Int J Med Biol Front; 2013; 19(2):. PubMed ID: 25339844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluoxetine in depressed AUD adolescents: a 1-year follow-up evaluation.
    Cornelius JR; Bukstein OG; Salloum IM; Kelly TM; Wood DS; Clark DB
    J Child Adolesc Psychopharmacol; 2004; 14(1):33-8. PubMed ID: 15142389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The short-term safety and efficacy of fluoxetine in depressed adolescents with alcohol and cannabis use disorders: a pilot randomized placebo-controlled trial.
    Findling RL; Pagano ME; McNamara NK; Stansbrey RJ; Faber JE; Lingler J; Demeter CA; Bedoya D; Reed MD
    Child Adolesc Psychiatry Ment Health; 2009 Mar; 3(1):11. PubMed ID: 19298659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluoxetine in adolescents with comorbid major depression and an alcohol use disorder: a 3-year follow-up study.
    Cornelius JR; Clark DB; Bukstein OG; Kelly TM; Salloum IM; Wood DS
    Addict Behav; 2005 May; 30(4):807-14. PubMed ID: 15833583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating the substance-abusing suicidal patient.
    Cornelius JR; Salloum IM; Lynch K; Clark DB; Mann JJ
    Ann N Y Acad Sci; 2001 Apr; 932():78-90; discussion 91-3. PubMed ID: 11411192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute phase and five-year follow-up study of fluoxetine in adolescents with major depression and a comorbid substance use disorder: a review.
    Cornelius JR; Clark DB; Bukstein OG; Birmaher B; Salloum IM; Brown SA
    Addict Behav; 2005 Oct; 30(9):1824-33. PubMed ID: 16102905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive-behavioural therapy and short-term psychoanalytic psychotherapy versus brief psychosocial intervention in adolescents with unipolar major depression (IMPACT): a multicentre, pragmatic, observer-blind, randomised controlled trial.
    Goodyer IM; Reynolds S; Barrett B; Byford S; Dubicka B; Hill J; Holland F; Kelvin R; Midgley N; Roberts C; Senior R; Target M; Widmer B; Wilkinson P; Fonagy P
    Health Technol Assess; 2017 Mar; 21(12):1-94. PubMed ID: 28394249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mirtazapine in Comorbid Major Depression and Alcohol Use Disorder: A Long-Term Follow-Up Study.
    Cornelius JR; Douaihy AB; Clark DB; Daley DC; Chung TA; Wesesky MA; Wood DS; Salloum I
    J Addict Behav Ther Rehabil; 2013 Aug; 3(1):. PubMed ID: 25374892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continued Effectiveness of Relapse Prevention Cognitive-Behavioral Therapy Following Fluoxetine Treatment in Youth With Major Depressive Disorder.
    Emslie GJ; Kennard BD; Mayes TL; Nakonezny PA; Moore J; Jones JM; Foxwell AA; King J
    J Am Acad Child Adolesc Psychiatry; 2015 Dec; 54(12):991-8. PubMed ID: 26598474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cannabis withdrawal is common among treatment-seeking adolescents with cannabis dependence and major depression, and is associated with rapid relapse to dependence.
    Cornelius JR; Chung T; Martin C; Wood DS; Clark DB
    Addict Behav; 2008 Nov; 33(11):1500-1505. PubMed ID: 18313860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial interventions for cannabis use disorder.
    Gates PJ; Sabioni P; Copeland J; Le Foll B; Gowing L
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD005336. PubMed ID: 27149547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder.
    Tomko RL; Baker NL; Hood CO; Gilmore AK; McClure EA; Squeglia LM; McRae-Clark AL; Sonne SC; Gray KM
    Psychopharmacology (Berl); 2020 Feb; 237(2):479-490. PubMed ID: 31712969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.